Latest Urinary bladder Stories

BELLEVILLE, ON, Nov. 15, 2011 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, offers its sincere congratulations to Dr. Alvaro Morales who became a Member of the Order of Canada earlier this month in recognition of his contributions to advancing the field of urology, notably in the areas of oncology and sexual dysfunction. Dr. Morales was the Principal Investigator in the Phase I and II...

EAST NORRITON, Pa., Nov. 10, 2011 /PRNewswire/ -- Tengion, Inc. (NASDAQ: TNGN), a leader in regenerative medicine, today announced that Brian Davis, Vice President Finance and Chief Financial Officer of Tengion, will present at the upcoming Lazard Capital Markets 8th Annual Healthcare Conference on Wednesday, November 16, 2011 at 8:30 a.m. EST. A live audio webcast of the presentation can be accessed at http://wsw.com/webcast/lz11/tngn/ or under "Calendar of Events" in the Investors...

MINNEAPOLIS, Nov., 9, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced the issuance of United States Patent No. 8,046,082 covering the stimulator used in the Urgent® PC Neuromodulation System. The Urgent PC Neuromodulation System is an office-based, non-surgical system, used to treat overactive bladder syndrome (OAB) and the associated...

EAST NORRITON, Pa., Nov. 7, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Monday, November 14, 2011 at 5:00 p.m. EST to provide a business update and discuss its third quarter 2011 financial results. To participate in the call, please dial 1-800-299-0148 (domestic) or 1-617-801-9711 (international) and reference access code 45190334. This conference call will...

EAST NORRITON, Pa., Nov. 7, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN) today announced the publication of key preclinical data for its Neo-GI Augment(TM) program in the scientific journal Regenerative Medicine. Using its proprietary Organ Regeneration Platform(TM), Tengion has demonstrated that smooth muscle cells seeded on its biological scaffolding and then implanted in rodents exhibit functional regeneration of both the inner lining of epithelial cells and the surrounding layers...

According to recent statistics, approximately 30 million Americans have been diagnosed with diabetes and close to 79 million are pre-diabetic. It is a lesser-known fact that between 2004 and 2009, more than 500,000 adverse reactions among people taking anti-diabetic drugs were added to an official U.S. Food and Drug Administration database. James Christopher Dean, an experienced defective drug Attorney, has released a new Actos website, http://www.LawyerforActos.com, with his concern of...

Normally, men can control the muscles that keep urine in the bladder so they go only when they want to. But sometimes men may leak urine when they don’t want to. Leaks may happen once in a while or more often. Go Guy is a small bag (pocket urinal) men carry in their pocket for emergency relief when the need arises for incontinence patients. Pawtucket, Rhode island (PRWEB) October 27, 2011 Urgency incontinence is a condition in which men lose urine with a strong sudden urge to go...

Curbita Bladder Caps will be featured in the November issue of Better Nutrition as a Best of Supplements Ghent, NY (PRWEB) October 20, 2011 Bioforce USA is proud to announce that Curbita Bladder Caps has been named Best of Supplements from Better Nutrition magazine. Curbita is a soft gel capsule that contains 1000 mgs of rare cold pressed European pumpkinseed oil, derived exclusively from the special medicinal pumpkin. Oil from this special pumpkin has long been used traditionally to...

CAMPBELL, Calif., Oct. 14, 2011 /PRNewswire/ -- EMKinetics, Inc. announced today initiation of the TranStim(TM) Transdermal Neuromodulation System pivotal trial for patients suffering from urge incontinence and overactive bladder. The 120-person trial will be conducted at 10-15 US centers. Submission for CE mark and 510(k) clearance will follow the completion of the study. EMKinetics' TranStim therapy builds on the body of evidence that posterior tibial nerve stimulation (PTNS) can...

Fifth Most Frequently Diagnosed Cancer in U.S. Affects Approximately 70,000 Americans Each Year Denver, CO (PRWEB) September 19, 2011 Bladder cancer is the fifth most commonly diagnosed cancer in the United States, yet most people know nothing about it. To help enhance the public’s understanding of the risks and signs of bladder cancer and the importance of early detection and treatment options, the Bladder Cancer Advocacy Network (BCAN) will hold a regional Bladder Cancer Patient...